Breakfast Sessions

THURSDAY SEPTEMBER 28

7:00 – 8:15 a.m. | Breakfast Sessions

 

FRIDAY SEPTEMBER 29

7:00 – 8:15 a.m. | Breakfast Sessions

 

SATURDAY SEPTEMBER 30

7:00 – 8:15 a.m. | Breakfast Session

 

Back to top

 

 

Advancing Clinical Practice through Improved BRCA1/2 Testing Processes
Thursday September 28, 7:00 – 8:15 a.m.

 

Presented by

AstraZeneca

 

Speakers:
Aalok Kumar, MD, MHSc, FRCPC, Medical Oncologist / Clinical Assistant Professor, BC Cancer Agency – Fraser Valley / University of British Columbia
Melanie Care, MSc, CCGC, Genetic Counsellor, Genome Diagnostics, Department of Clinical Laboratory Genetics, University Health Network – Toronto General Hospital

 

Objectives:

At the end of this session, participants will be able to:

  • Examine how BRCA1/2 testing is increasingly used to guide clinical management decisions related to targeted therapies.
  • Evaluate the utility of germline and tumour-based BRCA1/2 mutation testing.
  • Summarize potential clinical care models for implementing tumour-based BRCA1/2 mutation testing.
  • Identify the role of the multidisciplinary team in optimizing tumour and germline BRCA1/2 mutation testing workflows.

 

The seminar will provide education on a new targeted therapy that requires assessment of a patient’s BRCA1/2 tumour and / or germline mutation status. Changes to the clinical workflow and multidisciplinary coordination will be reviewed, as they are important for optimal clinical management. Clinical information will be provided on the impact of the targeted therapy, and models will be reviewed regarding combined tumour and germline molecular testing. Case studies will be referenced to convey the program elements.

 

Registration for this breakfast is now closed.

 

Back to top

 

Updates on Epilepsy: Genetic Testing of the “Sacred Disease”
Thursday September 28, 7:00 – 8:15 a.m.

 

Presented by

Quest Diagnostics

 

Speaker: Tracy Futch, MS, PhD, CGC, Genetic Counselor – Advanced Diagnostics, Quest Diagnostics

 

Objectives:

At the end of this session, participants will be able to:

  • Examine the etiology of epilepsy.
  • Examine the role of genetic testing in epilepsy.
  • Summarize genetic testing approaches.

 

This presentation will provide background information on the causes of epilepsy and recent updates on the role of genetics. There will be a focus on how genetic testing can benefit both diagnosing as well as treating epilepsy. Discussion will include advantages and disadvantages of different technologies and approaches.

 

Registration for this breakfast is now closed.

 

Back to top

 

Exome For All: Guide Your Health
Friday September 29, 7:00 – 8:15 a.m.

 

Presented by

Ambry Genetics

 

Speaker: Layla Shahmirzadi Mowlavi, MS, CGC, Clinical Product Development Manager, Ambry Genetics

 

Objectives:

At the end of this session, participants will be able to:

  • Review current testing options for asymptomatic ‘healthy’ individuals.
  • Assess the likelihood of positive findings among ‘healthy’ individuals based on data from prior studies and secondary findings results.
  • Describe consumer motivations and perceived interest in genomic testing.
  • Discuss a suggested framework for offering responsible and accurate personalized genomic testing.

 

This presentation will review the current state of personalized genomic testing and whether or not we are ready genomic testing of ‘healthy’ individuals.

 

Registration for this breakfast is now closed.

 

Back to top

 

A New Approach to Genetic Counseling and Testing: Key Clinical Findings
Friday September 29, 7:00 – 8:15 a.m.

 

Presented by

Color

 

Speaker: Cynthia Handford, MSc, LCGC, CCGC, Genetic Counsellor, Color Genomics, Inc.

 

Objectives:

At the end of this session, participants will be able to:

  • Compare positive rates by gene and by personal and family history.
  • Examine the number of concurrent mutations found.
  • Summarize case reports that illustrate the value of broader testing approaches.

 

Color Genomics offers high quality genetic testing for hereditary cancer risk in an innovative service delivery model that reduces barriers to accessing genetic counseling and testing. This talk will review key findings from results of individuals who have taken the Color Test.

 

Registration for this breakfast is now closed.

 

Back to top

 

Exome Sequencing in a Clinical Laboratory
Saturday September 30, 7:00 – 8:15 a.m.

 

Presented by

GeneDx

 

Speakers:
Jane Juusola, PhD, FACMG, Clinical Molecular Geneticist, Director of Clinical Genomics, Gene Dx
Hana Sroka, CGC, CCGC, Genetic Counsellor, Gene Dx

 

Objectives:
1. Summarize the approach taken to analyze and interpret clinical exome data, especially in a prenatal or NICU/PICU setting
2. Describe the evolution of genes from candidate to disease-causing
3. Identify why reanalyzing exome data is important

 

A behind-the-scenes look at clinical exome sequencing analysis and interpretation providing a framework of understanding including how evolution of genomics plays an important role. This presentation may be useful for genetic counsellors not only wishing to expand their exome sequencing knowledge base but also those looking to gain insight into the interplay and value of various key components contributing to their patient’s result.

 

Registration for this breakfast is now closed.

 

Back to top

 

How Laboratory Genetic Counsellors Contribute to Ensuring Quality Results for Patients
Saturday September 30, 7:00 – 8:15 a.m.

 

Presented by

Prevention Genetics

 

Speakers:
Connie Schultz, MS, CGC, PreventionGenetics
Rachel Vanneste, MSc, CCGC, CGC, PreventionGenetics

 

Objectives:

At the end of this session, participants will be able to:

  • Describe the variety of ways in which lab genetic counsellors work to ensure patients receive appropriate testing and quality results.
  • Examine the different ways in which genetic counsellors and genetic counselling assistants contribute to laboratory stewardship / utilization management.
  • Evaluate the principle of “Value = Quality / Cost” and what genetic counsellors bring to that equation.

 

This session will use information alongside case examples to describe the variety of roles that that laboratory genetic counsellors play in ensuring that patients get the right test at the right time. This talk might also be useful to genetic counsellors who would like to learn more about the variety of roles that GCs and genetic counselling assistants can play in private laboratories and how they can contribute to appropriate patient care.

 

Registration for this breakfast is now closed.

 

Back to top